BNTX logo

BioNTech SE (BNTX) Revenue

BNTX Annual Revenue

$4.13 B
-$14.12 B-77.35%

31 December 2023

BNTX Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BNTX Quarterly Revenue

$1.37 B
+$1.23 B+887.92%

01 September 2024

BNTX Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BNTX TTM Revenue

$3.30 B
+$394.25 M+13.55%

01 September 2024

BNTX TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BNTX Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-77.3%-14.1%-19.8%
3 y3 years+650.6%-80.9%-87.8%
5 y5 years+2644.6%+4195.7%+1672.3%

BNTX Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.6%at low-80.9%+887.9%-87.8%+13.6%
5 y5-year-81.6%+3300.7%-80.9%+4378.6%-87.8%+2618.3%
alltimeall time-81.6%+5826.7%-80.9%+5672.4%-87.8%>+9999.0%

BioNTech SE Revenue History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.37 B(+887.9%)
$3.30 B(+13.5%)
June 2024
-
$138.58 M(-32.0%)
$2.91 B(-1.5%)
Mar 2024
-
$203.77 M(-87.2%)
$2.95 B(-28.3%)
Dec 2023
$4.13 B(-77.4%)
$1.59 B(+63.4%)
$4.12 B(-40.3%)
Sept 2023
-
$974.79 M(+433.1%)
$6.90 B(-26.7%)
June 2023
-
$182.87 M(-86.7%)
$9.42 B(-25.5%)
Mar 2023
-
$1.37 B(-68.6%)
$12.64 B(-31.4%)
Dec 2022
$18.26 B(-18.7%)
$4.37 B(+25.5%)
$18.42 B(-9.6%)
Sept 2022
-
$3.49 B(+2.4%)
$20.37 B(-15.3%)
June 2022
-
$3.40 B(-52.4%)
$24.06 B(-11.1%)
Mar 2022
-
$7.15 B(+13.0%)
$27.06 B(+20.9%)
Dec 2021
$22.45 B
$6.33 B(-11.8%)
$22.37 B(+36.0%)
Sept 2021
-
$7.18 B(+12.2%)
$16.46 B(+75.9%)
DateAnnualQuarterlyTTM
June 2021
-
$6.40 B(+159.2%)
$9.36 B(+211.4%)
Mar 2021
-
$2.47 B(+499.4%)
$3.01 B(+429.8%)
Dec 2020
$550.80 M(+353.0%)
$411.82 M(+421.7%)
$567.25 M(+204.3%)
Sept 2020
-
$78.93 M(+71.9%)
$186.43 M(+33.8%)
June 2020
-
$45.92 M(+50.2%)
$139.37 M(+13.9%)
Mar 2020
-
$30.57 M(-1.4%)
$122.41 M(+0.7%)
Dec 2019
$121.58 M(-19.3%)
$31.00 M(-2.7%)
$121.55 M(-25.6%)
Sept 2019
-
$31.87 M(+10.0%)
$163.31 M(+5.3%)
June 2019
-
$28.97 M(-2.5%)
$155.16 M(+23.0%)
Mar 2019
-
$29.71 M(-59.2%)
$126.19 M(+30.8%)
Dec 2018
$150.64 M(+115.9%)
$72.77 M(+206.8%)
$96.49 M(+306.8%)
Sept 2018
-
$23.72 M
$23.72 M
Dec 2017
$69.76 M
-
-

FAQ

  • What is BioNTech SE annual revenue?
  • What is the all time high annual revenue for BioNTech SE?
  • What is BioNTech SE annual revenue year-on-year change?
  • What is BioNTech SE quarterly revenue?
  • What is the all time high quarterly revenue for BioNTech SE?
  • What is BioNTech SE quarterly revenue year-on-year change?
  • What is BioNTech SE TTM revenue?
  • What is the all time high TTM revenue for BioNTech SE?
  • What is BioNTech SE TTM revenue year-on-year change?

What is BioNTech SE annual revenue?

The current annual revenue of BNTX is $4.13 B

What is the all time high annual revenue for BioNTech SE?

BioNTech SE all-time high annual revenue is $22.45 B

What is BioNTech SE annual revenue year-on-year change?

Over the past year, BNTX annual revenue has changed by -$14.12 B (-77.35%)

What is BioNTech SE quarterly revenue?

The current quarterly revenue of BNTX is $1.37 B

What is the all time high quarterly revenue for BioNTech SE?

BioNTech SE all-time high quarterly revenue is $7.18 B

What is BioNTech SE quarterly revenue year-on-year change?

Over the past year, BNTX quarterly revenue has changed by -$223.70 M (-14.05%)

What is BioNTech SE TTM revenue?

The current TTM revenue of BNTX is $3.30 B

What is the all time high TTM revenue for BioNTech SE?

BioNTech SE all-time high TTM revenue is $27.06 B

What is BioNTech SE TTM revenue year-on-year change?

Over the past year, BNTX TTM revenue has changed by -$817.81 M (-19.84%)